Designing & Developing Novel Platform Technology for Sustained Release of Various Therapeutic Modalities via Cochlear Implant Device
Time: 9:30 am
day: Conference Day 2
Details:
- Developing sustained release drug formulations delivered via implantable pellets embedded into the cochlea, on a cochlear implant electrode or in a hydrogel
- Understanding the FDA’s criteria for successful outcome measures for inner ear drug therapeutics and cochlear implants; device improvement and drug efficacy
- Reviewing regulatory discussions to gain approval for drug/device combination products
